Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acetylcholine receptors (AChRs) are integral membrane proteins that respond to the binding of acetylcholine, a neurotransmitter. They play crucial roles in neurotransmission throughout the nervous system. They are classified into two major types: nicotinic acetylcholine receptors (nAChRs), which are ionotropic receptors functioning as ligand-gated ion channels, and muscarinic acetylcholine receptors (mAChRs), which are metabotropic receptors belonging to the G protein-coupled receptor (GPCR) superfamily. AChRs mediate the effects of acetylcholine throughout the nervous system and in non-nervous tissues and are considered important therapeutic targets in various neurological and neuromuscular conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acetylcholine receptors (AChRs).